Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Dietmar Berger is Chief Medical Officer at Gilead Sciences. OQRO lists 15 transactions filed with the SEC under this name, the latest on Sep 11, 2026, each linked to the official Form 4.
Chief Medical Officer
Disclosures on record
15
Companies involved
1
Gilead SciencesGILD
15 disclosures · Jan 2026 – Sep 2026
Sep 10, 2026533disclosed Sep 11
DetailsOfficial recordSep 10, 2026533disclosed Sep 11
DetailsOfficial recordSep 10, 2026263disclosed Sep 11
DetailsOfficial recordJun 10, 2026533disclosed Jun 11
DetailsOfficial recordJun 10, 2026533disclosed Jun 11
DetailsOfficial recordJun 10, 2026263disclosed Jun 11
DetailsOfficial recordMar 10, 20268,415disclosed Mar 12
DetailsOfficial recordMar 10, 202631Kdisclosed Mar 12
DetailsOfficial recordMar 10, 20262,133disclosed Mar 12
DetailsOfficial recordMar 10, 20262,133disclosed Mar 12
DetailsOfficial recordMar 10, 20261,063disclosed Mar 12
DetailsOfficial recordFeb 27, 20268,530disclosed Mar 2
DetailsOfficial recordJan 2, 202616Kdisclosed Jan 5
DetailsOfficial recordJan 2, 202616Kdisclosed Jan 5
DetailsOfficial recordJan 2, 20266,944disclosed Jan 5
DetailsOfficial recordAs of the latest filing on , Dietmar Berger reported holding 19,522 shares of Gilead Sciences (GILD), worth about $3.3M at the last close of $169 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Gilead Sciences GILD | 19,522 | 20K direct | $169 | $3.3M | Sep 10, 2026 |
Is this Dietmar Berger’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Sep 10, 2026, Dietmar Berger reported holding 19,522 shares of Gilead Sciences (GILD). At the last close of $169 on Nov 18, 2026, that is about $3.3M. This is the stake disclosed in filings, not a net worth.
No public filing gives Dietmar Berger's net worth. What SEC Form 4 shows is the stock stake: 19,522 shares of Gilead Sciences (GILD), about $3.3M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.